Compare SUNS & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUNS | XGN |
|---|---|---|
| Founded | 2023 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7M | 110.7M |
| IPO Year | 2024 | 2014 |
| Metric | SUNS | XGN |
|---|---|---|
| Price | $6.96 | $8.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $10.25 | ★ $10.57 |
| AVG Volume (30 Days) | 79.8K | ★ 331.1K |
| Earning Date | 11-10-2026 | 11-10-2026 |
| Dividend Yield | ★ 17.86% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $21,571,434.00 | N/A |
| Revenue This Year | $91.54 | $11.02 |
| Revenue Next Year | $12.74 | $10.28 |
| P/E Ratio | $12.43 | ★ N/A |
| Revenue Growth | ★ 102.96 | N/A |
| 52 Week Low | $5.77 | $2.59 |
| 52 Week High | $10.45 | $10.83 |
| Indicator | SUNS | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 54.43 | 54.61 |
| Support Level | $6.20 | $7.81 |
| Resistance Level | $7.90 | $8.94 |
| Average True Range (ATR) | 0.27 | 0.54 |
| MACD | 0.09 | 0.05 |
| Stochastic Oscillator | 80.00 | 70.49 |
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.